AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Biotherapy

Results: 26-50/193

Authors: MIGLIACCIO AR MIGLIACCIO G
Citation: Ar. Migliaccio et G. Migliaccio, THE MAKING OF AN ERYTHROID CELL - MOLECULAR CONTROL OF HEMATOPOIESIS, Biotherapy, 10(4), 1998, pp. 251-268

Authors: WENDLING F COHENSOLAL K VILLEVAL JL DEBILI N VAINCHENKER W
Citation: F. Wendling et al., MPL LIGAND OR THROMBOPOIETIN - BIOLOGICAL-ACTIVITIES, Biotherapy, 10(4), 1998, pp. 269-277

Authors: MAGLI MC
Citation: Mc. Magli, THE ROLE OF HOMEOBOX GENES IN HEMATOPOIESIS, Biotherapy, 10(4), 1998, pp. 279-294

Authors: ERIDANI S MAZZA U MASSARO P LATARGIA ML MAIOLO AT MOSCA A
Citation: S. Eridani et al., CYTOKINE EFFECT ON EX-VIVO EXPANSION OF HEMATOPOIETIC STEM-CELLS FROMDIFFERENT HUMAN SOURCES, Biotherapy, 10(4), 1998, pp. 295-298

Authors: AVANZI GC GALLICCHIO M SAGLIO G
Citation: Gc. Avanzi et al., HEMATOPOIETIC GROWTH-FACTORS IN AUTOLOGOUS TRANSPLANTATION, Biotherapy, 10(4), 1998, pp. 299-308

Authors: PINTO A GATTEI V ZAGONEL V ALDINUCCI D DEGAN M DEIULIIS A ROSSI FM MAZZOCCO FT GODEAS C RUPOLO M POLETTO D GLOGHINI A CARBONE A GRUSS HJ
Citation: A. Pinto et al., HODGKINS-DISEASE - A DISORDER OF DYSREGULATED CELLULAR CROSS-TALK, Biotherapy, 10(4), 1998, pp. 309-320

Authors: REVOLTELLA RP
Citation: Rp. Revoltella, NATURAL AND THERAPEUTICALLY-INDUCED ANTIBODIES TO CYTOKINES, Biotherapy, 10(4), 1998, pp. 321-331

Authors: VANEDEN W
Citation: W. Vaneden, SPECIAL ISSUE - HEAT-SHOCK PROTEINS AS A TARGET FOR THE TREATMENT OF DISEASE - PREFACE, Biotherapy, 10(3), 1998, pp. 171-171

Authors: MIZZEN L
Citation: L. Mizzen, IMMUNE-RESPONSES TO STRESS PROTEINS - APPLICATIONS TO INFECTIOUS-DISEASE AND CANCER, Biotherapy, 10(3), 1998, pp. 173-189

Authors: GELUK A TANEJA V VANMEIJGAARDEN KE DEVRIES RRP DAVID CS OTTENHOFF THM
Citation: A. Geluk et al., HLA-DR DQ TRANSGENIC, CLASS-II DEFICIENT MICE AS A NOVEL MODEL TO SELECT FOR HSP T-CELL EPITOPES WITH IMMUNOTHERAPEUTIC OR PREVENTATIVE VACCINE POTENTIAL/, Biotherapy, 10(3), 1998, pp. 191-196

Authors: GASTON JSH
Citation: Jsh. Gaston, HEAT-SHOCK PROTEINS AS POTENTIAL TARGETS IN THE THERAPY OF INFLAMMATORY ARTHRITIS, Biotherapy, 10(3), 1998, pp. 197-203

Authors: PRAKKEN B WAUBEN M VANKOOTEN P ANDERTON S VANDERZEE R KUIS W VANEDEN W
Citation: B. Prakken et al., NASAL ADMINISTRATION OF ARTHRITIS-RELATED T-CELL EPITOPES OF HEAT-SHOCK-PROTEIN-60 AS A PROMISING WAY FOR IMMUNOTHERAPY IN CHRONIC ARTHRITIS, Biotherapy, 10(3), 1998, pp. 205-211

Authors: BONNIN D ALBANI S
Citation: D. Bonnin et S. Albani, MUCOSAL MODULATION OF IMMUNE-RESPONSES TO HEAT-SHOCK PROTEINS IN AUTOIMMUNE ARTHRITIS, Biotherapy, 10(3), 1998, pp. 213-221

Authors: WENDLING U FARINE JC
Citation: U. Wendling et Jc. Farine, ORAL-ADMINISTRATION OF HSP-CONTAINING ESCHERICHIA-COLI EXTRACT OM-89 HAS SUPPRESSIVE EFFECTS IN AUTOIMMUNITY - REGULATION OF AUTOIMMUNE PROCESSES BY MODULATING PERIPHERAL IMMUNITY TOWARDS HSPS, Biotherapy, 10(3), 1998, pp. 223-227

Authors: HARADA M KIMURA G NOMOTO K
Citation: M. Harada et al., HEAT-SHOCK PROTEINS AND THE ANTITUMOR T-CELL RESPONSE, Biotherapy, 10(3), 1998, pp. 229-235

Authors: VANNOORT JM
Citation: Jm. Vannoort, ANTIGEN-SPECIFIC THERAPIES IN MULTIPLE-SCLEROSIS, Biotherapy, 10(3), 1998, pp. 237-250

Authors: WAKASUGI T TAKEDA T MONDEN T KATSUMOTO Y SAKITA I NAGAOKA H FUKUNAGA M TOMITA N KOBAYASHI T SHIOZAKI H SHIMANO T MONDEN M
Citation: T. Wakasugi et al., AUGMENTATION OF SPLENIC ANTITUMOR IMMUNITY BY LOCAL IMMUNOTHERAPY IN GASTRIC-CANCER PATIENTS, Biotherapy, 10(2), 1997, pp. 99-106

Authors: RIVERO J FRAGA M CANCIO I CUERVO J LOPEZSAURA P
Citation: J. Rivero et al., LONG-TERM TREATMENT WITH RECOMBINANT INTERFERON-ALPHA-2B PROLONGS SURVIVAL OF ASYMPTOMATIC HIV-INFECTED INDIVIDUALS, Biotherapy, 10(2), 1997, pp. 107-113

Authors: YOSHIDA T SAEKI T AOYAMA Y OKUDAIRA T OKADA T FUNASAKA S
Citation: T. Yoshida et al., TREATMENT OF HEAD AND NECK CANCERS WITH BRMS - PROLONGATION OF SURVIVAL, Biotherapy, 10(2), 1997, pp. 115-120

Authors: KUMAE T SABURI Y NASU M
Citation: T. Kumae et al., IN-VIVO AND IN-VITRO EFFECTS OF SIZOFIRAN ON THE HUMAN NEUTROPHILS AND THE SERUM OPSONIC ACTIVITY, Biotherapy, 10(2), 1997, pp. 121-127

Authors: BRAUNSCHWEIGER PG BASRUR VS CAMERON D SHARPE L SANTOS O PERRAS JP SEVIN BU MARKOE AM
Citation: Pg. Braunschweiger et al., MODULATION OF CISPLATIN CYTOTOXICITY BY INTERLEUKIN-1-ALPHA AND RESIDENT TUMOR MACROPHAGES, Biotherapy, 10(2), 1997, pp. 129-137

Authors: SASAKI H KOBAYASHI M EMORI Y OHYA O HAYASHI Y NOMOTO K
Citation: H. Sasaki et al., Z-100, A POLYSACCHARIDE-RICH PREPARATION EXTRACTED FROM THE HUMAN TYPE MYCOBACTERIUM-TUBERCULOSIS, IMPROVES THE RESISTANCE OF METH-A TUMOR-BEARING MICE TO ENDOGENOUS SEPTIC INFECTION, Biotherapy, 10(2), 1997, pp. 139-143

Authors: COYNE CP FENWICK BW AINSWORTH J
Citation: Cp. Coyne et al., CYTOTOXIC ACTIVITY OF DOXORUBICIN LOADED NEUTROPHILS AGAINST HUMAN MAMMARY-CARCINOMA (HTB-19), Biotherapy, 10(2), 1997, pp. 145-159

Authors: SOSNOWSKA D MYSLIWSKI A DZIERZBICKA K KOLODZIEJCZYK AM
Citation: D. Sosnowska et al., THE IN-VITRO EFFECT OF NEW MURAMYL PEPTIDE DERIVATIVES ON CYTOTOXIC ACTIVITY OF NK (NATURAL-KILLER) CELLS FROM HAMSTERS BEARING AB-BOMIRSKI-MELANOMA, Biotherapy, 10(2), 1997, pp. 161-168

Authors: OBERG K ALM G
Citation: K. Oberg et G. Alm, THE INCIDENCE AND CLINICAL-SIGNIFICANCE OF ANTIBODIES TO INTERFERON-AIN PATIENTS WITH SOLID TUMORS, Biotherapy, 10(1), 1997, pp. 1-5
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>